Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Dermavant Sciences GmbH
🇨🇭
Switzerland
Country
🇨🇭
Switzerland
Ownership
Subsidiary
Established
2016-01-01
Employees
251
Market Cap
-
Website
https://dermavant.com
Clinical Trials
Related News
A Study of E6005 in Japanese Patients With Atopic Dermatitis
Phase 1
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Placebo
Drug: E6005
Subscribe
First Posted Date
2010-08-11
Last Posted Date
2018-03-01
Lead Sponsor
Dermavant Sciences GmbH
Target Recruit Count
40
Registration Number
NCT01179880
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy